Bioceres Crop Solutions Corp (BIOX)

Currency in USD
3.75
+0.05(+1.35%)
Closed·
After Hours
3.750.00(0.00%)
·
BIOX Scorecard
Full Analysis
Impressive gross profit margins
BIOX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.663.77
52 wk Range
3.5011.41
Key Statistics
Prev. Close
3.7
Open
3.76
Day's Range
3.66-3.77
52 wk Range
3.5-11.41
Volume
93.76K
Average Volume (3m)
130.21K
1-Year Change
-65.78%
Book Value / Share
4.92
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.38
Upside
+96.67%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Bioceres Crop Solutions Corp Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Bioceres Crop Solutions Corp Earnings Call Summary for Q2/2025

  • Bioceres Q2 2024 EPS at $0.0095, missing $0.18 forecast; revenue at $106.7M, below $155.92M expected; stock down 4.68% after-hours
  • Revenue declined 24% YoY due to Argentine market contraction; gross margin improved to 42%; adjusted EBITDA fell to $15.4M from $24M
  • Company transitioning to licensing-focused seed business model; aims for stable EBITDA in Q4 2024; expanding biologicals and high-margin products
  • Net debt increased to $238M with 3.3 leverage ratio; CEO acknowledges non-linear growth, emphasizes strategy refinement for predictability
  • Future EPS forecasts: $0.12 for Q4 2025, $0.38 for FY 2026; analysts maintain $7-13 price targets despite current undervaluation
Last Updated: 12/02/2025, 15:44
Read Full Transcript

Compare BIOX to Peers and Sector

Metrics to compare
BIOX
Peers
Sector
Relationship
P/E Ratio
−26.0x−0.1x2.6x
PEG Ratio
0.060.010.00
Price/Book
0.8x1.2x1.6x
Price / LTM Sales
0.6x2.4x1.3x
Upside (Analyst Target)
93.9%125.3%18.0%
Fair Value Upside
Unlock−0.9%1.8%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.38
(+96.67% Upside)

Earnings

Latest Release
May 21, 2025
EPS / Forecast
-0.0207 / -0.065
Revenue / Forecast
60.60M / 80.95M
EPS Revisions
Last 90 days

BIOX Income Statement

People Also Watch

92.87
GLOB
+4.56%
74.35
PAM
+0.51%
33.160
YPF
+2.35%
14.030
HMY
-1.34%
44.500
VIST
+1.60%

FAQ

What Stock Exchange Does Bioceres Crop Trade On?

Bioceres Crop is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Bioceres Crop?

The stock symbol for Bioceres Crop is "BIOX."

What Is the Bioceres Crop Market Cap?

As of today, Bioceres Crop market cap is 235.17M.

What Is Bioceres Crop's Earnings Per Share (TTM)?

The Bioceres Crop EPS (TTM) is -0.14.

When Is the Next Bioceres Crop Earnings Date?

Bioceres Crop will release its next earnings report on 10 Sept 2025.

From a Technical Analysis Perspective, Is BIOX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bioceres Crop Stock Split?

Bioceres Crop has split 0 times.

How Many Employees Does Bioceres Crop Have?

Bioceres Crop has 0 employees.

What is the current trading status of Bioceres Crop (BIOX)?

As of 26 Jul 2025, Bioceres Crop (BIOX) is trading at a price of 3.75, with a previous close of 3.70. The stock has fluctuated within a day range of 3.66 to 3.77, while its 52-week range spans from 3.50 to 11.41.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.